How do we determine what a fair price for a life-saving prescription medication should be? This month, we discuss what is means for a price to be “fair” and explore the current legal and economic landscape of prescription drug pricing in the US.
Lloyd Duplechan joins Ethics Talk to discuss his article, coauthored with Dr David Sine: “Roles of Environmental Services Workers’ Wages and Status in Patient Safety.”
Debbie Berkowitz joins Ethics Talk to discuss her article, coauthored with Anna D. Goff, Dr Kathleen Marie Fagan, and Dr Monica L. Gerrek: "Do Clinics in Meat and Poultry Plants Endanger Workers?”
Dr Emily Shearer joins Ethics Talk to discuss her article, coauthored with Dr Jay Baruch: "Decision Aids, Doorknob Moments, and Physician-Patient Solidarity in EDs.”
Dr Lisa Lehmann joins Ethics Talk to discuss “grateful patient programs,” pressures clinicians face to fundraise on behalf of health care organizations for which they work, and whether “VIP” care really is better for patients.
Dr Kimberly A. Singletary joins Ethics Talk to discuss her article, coauthored with Dr Marshall H. Chin: “What Should Antiracist Payment Reform Look Like?”
Dr Charles E. Binkley joins Ethics Talk to discuss his article, coauthored with David Kemp and Dr Brandi Braud Scully: “Should We Rely on AI to Help Avoid Bias in Patient Selection for Major Surgery?”
